These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 38954304)
1. Enhancement of the Clastogenic Effects of Topotecan In Vivo by Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. Zhanataev AK; Kulakova AV; Luzina OA; Khomenko TM; Volcho KP; Salakhutdinov NF; Durnev AD Bull Exp Biol Med; 2024 May; 177(1):30-34. PubMed ID: 38954304 [TBL] [Abstract][Full Text] [Related]
2. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models. Zakharenko AL; Luzina OA; Sokolov DN; Kaledin VI; Nikolin VP; Popova NA; Patel J; Zakharova OD; Chepanova AA; Zafar A; Reynisson J; Leung E; Leung IKH; Volcho KP; Salakhutdinov NF; Lavrik OI Eur J Med Chem; 2019 Jan; 161():581-593. PubMed ID: 30396105 [TBL] [Abstract][Full Text] [Related]
3. The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo. Chernyshova IA; Zakharenko AL; Kurochkin NN; Dyrkheeva NS; Kornienko TE; Popova NA; Nikolin VP; Ilina ES; Zharkov TD; Kupryushkin MS; Oslovsky VE; Drenichev MS; Lavrik OI Molecules; 2022 Dec; 28(1):. PubMed ID: 36615517 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of the Antitumor and Antimetastatic Effect of Topotecan and Normalization of Blood Counts in Mice with Lewis Carcinoma by Tdp1 Inhibitors-New Usnic Acid Derivatives. Kornienko TE; Chepanova AA; Zakharenko AL; Filimonov AS; Luzina OA; Dyrkheeva NS; Nikolin VP; Popova NA; Salakhutdinov NF; Lavrik OI Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279210 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Activities of 11- and 12-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. Yang H; Qin C; Wu M; Wang FT; Wang W; Agama K; Pommier Y; Hu DX; An LK ChemMedChem; 2023 May; 18(10):e202200593. PubMed ID: 36932053 [TBL] [Abstract][Full Text] [Related]
6. [Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma]. Dyrkheeva NS; Zakharenko AL; Novoselova ES; Chepanova AA; Popova NA; Nikolin VP; Luzina OA; Salakhutdinov NF; Ryabchikova EI; Lavrik OI Mol Biol (Mosk); 2021; 55(2):312-317. PubMed ID: 33871444 [TBL] [Abstract][Full Text] [Related]
7. Influence of Tyrosyl-DNA Phosphodiesterase 1 Inhibitor on the Proapoptotic and Genotoxic Effects of Anticancer Agent Topotecan. Chepanova AA; Zakharenko AL; Dyrkheeva NS; Chernyshova IA; Zakharova OD; Ilina ES; Luzina OA; Salakhutdinov NF; Lavrik OI Dokl Biochem Biophys; 2023 Feb; 508(1):25-30. PubMed ID: 36653585 [TBL] [Abstract][Full Text] [Related]
8. The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo. Nikolin VP; Popova NA; Kaledin VI; Luzina OA; Zakharenko AL; Salakhutdinov NF; Lavrik OI Clin Exp Metastasis; 2021 Oct; 38(5):431-440. PubMed ID: 34370156 [TBL] [Abstract][Full Text] [Related]
9. New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1. Dyrkheeva NS; Filimonov AS; Luzina OA; Orlova KA; Chernyshova IA; Kornienko TE; Malakhova AA; Medvedev SP; Zakharenko AL; Ilina ES; Anarbaev RO; Naumenko KN; Klabenkova KV; Burakova EA; Stetsenko DA; Zakian SM; Salakhutdinov NF; Lavrik OI Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768766 [TBL] [Abstract][Full Text] [Related]
10. New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan. Khomenko TM; Zakharenko AL; Kornienko TE; Chepanova AA; Dyrkheeva NS; Artemova AO; Korchagina DV; Achara C; Curtis A; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298106 [TBL] [Abstract][Full Text] [Related]
11. The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair Enzyme. Gladkova ED; Nechepurenko IV; Bredikhin RA; Chepanova AA; Zakharenko AL; Luzina OA; Ilina ES; Dyrkheeva NS; Mamontova EM; Anarbaev RO; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998385 [TBL] [Abstract][Full Text] [Related]
12. Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma. Koldysheva EV; Men'shchikova AP; Lushnikova EL; Popova NA; Kaledin VI; Nikolin VP; Zakharenko AL; Luzina OA; Salakhutdinov NF; Lavrik OI Bull Exp Biol Med; 2019 Mar; 166(5):661-666. PubMed ID: 30903487 [TBL] [Abstract][Full Text] [Related]
13. Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy. Komarova AO; Drenichev MS; Dyrkheeva NS; Kulikova IV; Oslovsky VE; Zakharova OD; Zakharenko AL; Mikhailov SN; Lavrik OI J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1415-1429. PubMed ID: 30191738 [TBL] [Abstract][Full Text] [Related]
18. Transcriptomic Analysis of CRISPR/Cas9-Mediated PARP1-Knockout Cells under the Influence of Topotecan and TDP1 Inhibitor. Dyrkheeva NS; Malakhova AA; Zakharenko AL; Okorokova LS; Shtokalo DN; Pavlova SV; Medvedev SP; Zakian SM; Nushtaeva AA; Tupikin AE; Kabilov MR; Khodyreva SN; Luzina OA; Salakhutdinov NF; Lavrik OI Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982223 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer. Hu DX; Tang WL; Zhang Y; Yang H; Wang W; Agama K; Pommier Y; An LK J Med Chem; 2021 Jun; 64(11):7617-7629. PubMed ID: 34008967 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their anticancer activity. Yang H; Wang FT; Wu M; Wang W; Agama K; Pommier Y; An LK Bioorg Chem; 2022 Jun; 123():105789. PubMed ID: 35429714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]